What is the current status of Stereotactic body radiotherapy for stage I non-small cell lung cancer?
- PMID: 22263080
- PMCID: PMC3256527
- DOI: 10.3978/j.issn.2072-1439.2011.06.04
What is the current status of Stereotactic body radiotherapy for stage I non-small cell lung cancer?
Conflict of interest statement
No potential conflict of interest.
References
-
- Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007;132:193–9. - PubMed
-
- Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: A population-based time-trend analysis. J Clin Oncol. 2010;28:5153–9. - PubMed
-
- Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable) Cochrane Database Syst Rev. 2001:CD002935. - PubMed
-
- Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys. 1998;40:149–54. - PubMed
-
- Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg. 2005;129:87–93. - PubMed
LinkOut - more resources
Full Text Sources